CD34+/CD41a+ cells best predict platelet recovery after autologous peripheral blood stem cell transplantation

Bone Marrow Transplantation

Volumn 21, Issue 12, 1998, Pages 1217-1222

  Feng, R ^a   Shimazaki, C ^a   Inaba, T ^a   Takahashi, R ^a   Hirai, H ^a   Kikuta, T ^a   Sumikuma, T ^a   Yamagata, N ^a   Ashihara, E ^a   Fujita, N ^a   Nakagawa, M ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

CD34; CFU MK; PBSCT; Platelet recovery; Thrombopoietin

Indexed keywords

BUFFER; CD34 ANTIGEN; EDETIC ACID; FIBRINOGEN RECEPTOR; GLYCOPROTEIN; MARKER; THROMBOPOIETIN;

ADULT; ARTICLE; AUTOGRAFT; CELL COUNT; CELL SELECTION; CLINICAL ARTICLE; CLONOGENIC ASSAY; COLONY FORMING UNIT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MEGAKARYOCYTE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL; STEM CELL TRANSPLANTATION; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE COUNT;

EID: 0031853937     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701273     Document Type: Article

References (31)

1. Kessinger A, Armitage JO. The evolving role of autologous peripheral blood stem cell transplantation following high-dose therapy for malignancies. Blood 1991; 77: 211-213.
2. Shimazaki C, Oku N, Ashihara E et al. Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 1992; 10: 341-346.
3. Gianni AM, Siena S, Bregni M et al. Granulocyte - macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989; 2: 580-585.
4. Sheridan WP, Bergley CG, Juttner CA et al. Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640-644.
5. Shimazaki C, Yamagata N, Tatsumi T et al. Mobilization of peripheral blood progenitor cells by high-dose Ara-C, VP-16 and recombinant human granulocyte colony-stimulating factor: factors affecting progenitor cell yields. Bone Marrow Transplant 1995; 15: 763-767.
6. Sudo Y, Shimazaki C, Ashihara E et al. Synergistic effect of FLT-3 ligand on the G-CSF-induced mobilization of hematopoietic primitive and committed progenitor cells into blood in mice. Blood 1997; 89: 3186-3191.
7. Bensinger WI, Longin K, Appelbaum F et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994; 87: 825-831.
8. + cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19: 303-310.
9. Siena S, Bregni M, Brando B et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400-409.
10. Ho AD, Gluck S, Germond C et al. Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte - macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer. Leukemia 1993; 7: 1738-1746.
11. Kawano Y, Takaue Y, Watanabe T et al. Effects of progenitor cell dose and preleukapheresis use of human recombinant gra-nulocyte colony stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children. Exp Hematol 1993; 21: 103-108.
12. Weaver CH, Hazelton B, Birch R et al. An analysis of engraftment kinnetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961-3969.
13. + cells and rapid hematopoietic recovery after peripheral blood stem cell transplantation. J Clin Oncol 1995; 13: 1922-1932.
14. Takamatsu Y, Harada M, Teshima T et al. Relationship of infused CFU-GM and CFU-MK mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous peripheral blood stem cell transplantation. Exp Hematol 1995; 23: 8-13.
15. Campos L, Bastion Y, Roubi N et al. Peripheral blood stem cells harvested after chemotherapy and GM-CSF for treatment intensification in patients with advanced lymphoproliferative diseases. Leukemia 1993; 7: 1409-1415.
16. + blood cells predict the colony-forming capacity of leukapheresis products in children. Bone Marrow Transplant 1995; 15: 25-31.
17. + cells measured under conditions that prevent P-selectin-mediated binding of platelets. Blood 1995; 86: 3771-3782.
18. de Sauvage FJ, Haas PE, Spencer SD et al. Stimulation of megakaryopoiesis and thrombopoiesis by the c-MPL ligand. Nature 1994; 369: 533-538.
19. Kaushansky K, Lok S, Holly RD et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994; 369: 568-571.
20. Kato T, Ogami K, Shimada Y et al. Purification and characterization of thrombopoietin. J Biochem 1995; 118: 229-236.
21. Nishihira H, Toyoda Y, Miyazaki H et al. Growth of macroscopic human megakaryocyte colonies from cord blood in culture with recombinant human thrombopoietin (c-mpl ligand) and the effects of gestational age on frequency of colonies. Br J Haematol 1996; 92: 23-28.
22. Inaba T, Shimazaki C, Hirata T et al. Phenotypic differences of CD34-positive stem cells harvested from peripheral blood and bone marrow obtained before and after peripheral blood stem cell collection. Bone Marrow Transplant 1994; 13: 527-532.
23. Emminger W, Emminger-Schmidmeier W, Hocker P et al. Myeloid progenitor cells (CFU-GM) predict engraftment kinetics in autologous transplantation in children. Bone Marrow Transplant 1989; 4: 415-420.
24. 8/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation. Exp Hematol 1995; 23: 1581-1588.
25. Jackson CW. Hematopoietic colony assays as predictors of platelet recovery after hematopoietic stem cell transplantation. Exp Hematol 1995; 23: 4-6.
26. Debili N, Issaad C, Masse JM et al. Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation. Blood 1992; 80: 3022-3035.
27. Bender JG, Williams SF, Myers S et al. Characterization of chemotherapy mobilized peripheral blood progenitor cells for use in autologous stem cell transplantation. Bone Marrow Transplant 1992; 10: 281-285.
28. + cells. Leukemia 1992; 6: 845-852.
29. Vainchenker W, Deschamps JE, Bastin JM et al. Two monoclonal antiplatelet antibodies as markers of human megakaryocyte maturation: immunofluorescent staining and platelet peroxidase detection in megakaryocyte colonies and in in vivo cells from normal and leukemic patients. Blood 1982; 59: 514-521.
30. Vinci G, Tabilio A, Deschamps JF et al. Immunological study of in vitro maturation of human megakaryocytes. Br J Haematol 1984; 56: 589-605.
31. Breton-Gorius J, Vainchenker W. Expression of platelet proteins during the in vitro and in vivo differentiation of megakaryocytes and morphological aspects of their maturation. Semin Hematol 1986; 23: 43-67.